Characterization of two monoclonal antibodies that capture and neutralize LSDV via distinct novel epitopes

Key Points

• Two distinct monoclonal antibodies effectively neutralize LSDV, indicating potential for treatment.
• The study outlines specific epitopes targeted by these antibodies, enhancing understanding of LSDV interactions.
• Characterization involved in vitro assays to evaluate the capture and neutralization of LSDV.
• Novel findings may lead to improved therapeutic strategies against LSDV in veterinary medicine.